Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Intravenous Estetrol in Healthy Volunteers
NCT05460065Phase 1Terminated
- Start
- Apr 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of estetrol in hypoxic-ischemic encephalopathy (HIE) (4 arms). Primary endpoints: Treatment-emergent adverse events, Serious adverse events and 4 more. Started Apr 2022; status: terminated.
02
Drugs
estetrol
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT05460065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05460065.